NFKB1 and Insulin resistance: In this study we investigated the effect of celastrol, an NF-κB inhibitor, on insulin resistance and diabetic nephropathy under the hypothesis that inhibition of the NF-κB pathway may improve insulin resistance and renal function through the modulation of inflammatory processes in both adipose tissues and kidneys in db/db mice.